DrugPatentWatch Database Preview

CEFADROXIL Drug Profile

« Back to Dashboard

Which patents cover Cefadroxil, and when can generic versions of Cefadroxil launch?

Cefadroxil is a drug marketed by Aurobindo Pharma, Cspc Ouyi Pharm Co, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms Inc, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy. and is included in twenty-three NDAs.

The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Nineteen suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.

Summary for CEFADROXIL

US Patents:	0
Applicants:	17
NDAs:	23
Suppliers / Packagers:	19
Bulk Api Vendors:	47
Clinical Trials:	7
Patent Applications:	3,598
Drug Prices:	see details
DailyMed Link:	CEFADROXIL at DailyMed

Pharmacology for CEFADROXIL

Ingredient-type	Cephalosporins
Drug Class	Cephalosporin Antibacterial

Synonyms for CEFADROXIL

(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid

(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

4-Hydroxycephalexin

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R,7R)-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-

50370-12-2

592C878

66592-87-8

7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetylamino](7R,7aR)-3-methyl-6-oxo-2H,7H-a zetidino[2,1-b]1,3-thiazine-4-carboxylic acid

7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-3,4-didehydrocepham-4-carboxylic acid

7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid

AB00513838

AC1L1E2B

AC1L2J3O

AC1Q6LPA

AKOS005622555

API0006601

AS-11655

AS-13773

Baxan

BB_NC-1256

BBL033696

BDBM50350467

Bidocef

BL-S 578

BL-S578

BOEGTKLJZSQCCD-UEKVPHQBSA-N

BPBio1_000494

BSPBio_000448

C06878

C16H17N3O5S

CAS-50370-12-2

CCG-220434

CDX

Cefa-Drops

Cefadrops

cefadrox

Cefadroxil (anhydrous)

Cefadroxil (JP15)

Cefadroxil (JP17)

Cefadroxil [INN]

Cefadroxil anhydrous

Cefadroxil monohydrate, Antibiotic for Culture Media Use Only

Cefadroxil, analytical standard

CEFADROXIL/CEFADROXIL HEMIHYDRATE

Cefadroxilo

Cefadroxilo [INN-Spanish]

Cefadroxilum

Cefadroxilum [INN-Latin]

Cefamox

Cefradroxil

Cephadroxil

Cephadroxyl

Cephos

CHEBI:3479

CHEMBL1555813

CHEMBL1644

CS-4696

CTK8F8512

Curisafe (TN)

D-Cefadroxil

D00257

D0X9ZC

DB01140

DivK1c_000409

DR001942

DSSTox_CID_2749

DSSTox_GSID_22749

DSSTox_RID_76714

DTXSID8022749

Duracef

Duricef

EINECS 256-555-6

Epitope ID:117131

FT-0603067

GTPL4831

HMS1569G10

HMS2096G10

HMS501E11

HY-B1190

I04-8441

IDI1_000409

J10293

KBio1_000409

KBio2_000544

KBio2_003112

KBio2_005680

KBioGR_000732

KBioSS_000544

Kefroxil

LS-149956

MCULE-6475996520

MCULE-6662086355

MJF-11567-3

MLS002207219

MolPort-002-507-346

MolPort-006-167-717

NCGC00016858-01

NCGC00094609-01

NCGC00094609-02

NCGC00179556-01

NCGC00179556-03

NINDS_000409

NSC-756664

NSC756664

Oracefal

p-Hydroxycephalexine

Pharmakon1600-01500163

Prestwick0_000434

Prestwick1_000434

Prestwick2_000434

Prestwick3_000434

Q525PA8JJB

S 578

S-578

SBI-0051305.P003

SC-74593

SCHEMBL13698957

SCHEMBL151320

Sedral

SMR001306770

SPBio_000014

SPBio_002387

Spectrum_000104

Spectrum2_000087

Spectrum4_000266

Spectrum5_000663

ST51014960

STK801939

Sumacef

Sumacef (TN)

Tox21_110651

Tox21_110651_1

Ultracef

UNII-Q525PA8JJB

ZINC3830391

US Patents and Regulatory Information for CEFADROXIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orchid Hlthcare	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	TABLET;ORAL	065301-001	Sep 18, 2006	AB	RX	No	No
Sun Pharm Inds Ltd	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	FOR SUSPENSION;ORAL	065115-001	Mar 26, 2003		DISCN	No	No
Ranbaxy	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	TABLET;ORAL	065018-001	Apr 23, 1999		DISCN	No	No
Sun Pharm Inds Ltd	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	FOR SUSPENSION;ORAL	065115-002	Mar 26, 2003		DISCN	No	No